39 Results for "

β-catenin/TCF

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "β-catenin/TCF" in MCE Product Catalog:

68
68 Publications Verification
Cat. No.: HY-14428
CAS No.: 780757-88-2
Purity:  99.86%
Target:  

β-catenin Apoptosis

Research Areas:  

Cancer

ICG-001 is an inhibitor of β-catenin/TCF mediated transcription. ICG-001 works by specifically binding to cyclic AMP response element-binding protein with an IC50 of 3 μM. ICG-001 selectively blocks the β-catenin/CBP interaction without interfering with the β-catenin/p300 interaction.
loading...
    loading...
67
67 Cited Publications
Cat. No.: HY-12238
CAS No.: 1127442-82-3
Purity:  99.60%
Synonyms: endo-IWR 1; IWR-1-endo
Target:  

Organoid Wnt

Research Areas:  

Inflammation/Immunology Cancer

IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM). IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-101486
CAS No.: 664969-54-4
Purity:  99.55%
Target:  

β-catenin

Research Areas:  

Cancer

LF3 is an antagonist of the β-Catenin/TCF4 interaction with antitumor activity; has an IC50 of 1.65 μM .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-11035
CAS No.: 1123231-07-1
Purity:  99.11%
Target:  

β-catenin Wnt

Research Areas:  

Cancer

WAY-262611 is a Wnt/β-Catenin agonist that increases bone formation rate with an EC50 of 0.63 μM in TCF-Luciferase assay. WAY-262611 is also a Dkk1 inhibitor .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-100760
CAS No.: 84-82-2
Purity:  99.88%
Synonyms: Xanthothricin; Toxoflavine; PKF-118-310
Toxoflavin (Xanthothricin) is an antagonist of transcription factor 4 (TCF4)/β-catenin complex, also acts as an inhibitor of KDM4A, with antitumor and antibiotic activity .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18959
CAS No.: 1144044-02-9
Target:  

β-catenin Wnt

Research Areas:  

Cancer

CWP232228, a highly potent selective Wnt/β-catenin signaling inhibitor, antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus. CWP232228 suppresses tumor formation and metastasis without toxicity through the inhibition of the growth of breast and liver cancer stem cells (CSCs) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B1360
CAS No.: 72-80-0
Synonyms: Chloquinan
Research Areas:  

Infection Cancer

Chlorquinaldol (Chloquinan) is an antibacterial agent with the potential use in topical skin conditions and vaginal infections. Chlorquinaldol is a β-catenin/TCF4 inhibitor, showing anti-proliferation, anti-migration, and apoptosis-inducing activity in cancer cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117233
CAS No.: 1500080-17-0
Purity:  99.63%
Target:  

β-catenin Wnt

Research Areas:  

Metabolic Disease Cancer

UU-T02 is a novel potent, selective small-molecule inhibitor of β-Catenin/T-cell factor protein-protein interaction (β-catenin/Tcf PPI) with a Ki of 1.36 μM . UU-T02 inhibits canonical Wnt signaling and the growth of colorectal cancer cells .
loading...
    loading...
Cat. No.: HY-P10925
CAS No.: 3044032-95-0
Synonyms: FOG-001; I-66
Target:  

β-catenin

Research Areas:  

Cancer

Zolucatetide (FOG-001;I-66) is a potent β-catenin inhibitor with an IC50 of <50 nM. Zolucatetide can inhibits β-catenin and T-cell factor (TCF) transcription factor interaction. Zolucatetide inhibits cell proliferation and induces cell cycle arrest in target cells. Zolucatetide exhibits anti-tumor efficacy in mice bearing COLO320DM colon cancer cell (with APC, TP53 mutations) xenografts. Zolucatetide can be used for the study of colon cancer .
loading...
    loading...
Cat. No.: HY-122649
CAS No.: 1417162-83-4
Purity:  96.92%
Target:  

β-catenin

Research Areas:  

Cancer

UU-T01 is a β-catenin inhibitor with a KD of 0.531 μM. UU-T01 binds to the K435, R469 and K508 residues of β-catenin, disrupting the β-catenin/TCF4 protein-protein interaction .
loading...
    loading...
Cat. No.: HY-P10392AF
Target:  

Wnt β-catenin

Research Areas:  

Cancer

fStAx-35R TFA is the hydrocarbon-stapled peptide. fStAx-35R TFA inhibits Wnt/β-catenin signaling pathway by disrupting the β-catenin-TCF interaction. fStAx-35R TFA can be used in cancer research .
loading...
    loading...
Cat. No.: HY-Y0315
CAS No.: 110-13-4
Synonyms: 2,5-HD
Hexane-2,5-dione (2,5-HD) is an orally active, CNS-penetrant cytotoxic agent . Hexane-2,5-dione reduces BCL-2 and β-catenin/TCF transcriptional activity, increases BAX and active caspase-3 expression, and promotes apoptosis. Hexane-2,5-dione causes an accumulation of neurofilaments within axons in rats. Hexane-2,5-dione can be used for the research of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-P10392B
Target:  

β-catenin Wnt

Research Areas:  

Cancer

aStAx-35R TFA, a stapled peptide, antagonizes nuclear form of β-catenin and inhibits Wnt signaling. aStAx-35R TFA inhibits competitively the binding of β-catenin to TCF4. aStAx-35R TFA selectively induces growth inhibition of Wnt-dependent cancer cells .
loading...
    loading...
Cat. No.: HY-N3393
CAS No.: 221289-31-2
Lethedioside A is a Enhancer of split 1 (Hes1) inhibitor with an IC50 of 9.5 μM. Lethedioside A inhibits Hes1 dimer formation. Lethedioside A exhibits weak inhibition of TCF4/β-catenin complex formation. Lethedioside A inhibits nitric oxide production by activated immune cells .
loading...
    loading...
Cat. No.: HY-119966
CAS No.: 305372-78-5
Purity:  99.42%
Target:  

Wnt β-catenin PPAR CDK

Research Areas:  

Cancer

CCT036477 is a Wnt/β-catenin pathway inhibitor. CCT036477 blocks transcription at β-catenin without altering its levels. CCT036477 inhibits proliferation of various cancer cells, development of embryos, and expression of Wnt target genes (PPARδ, Cyclin D1, TCF4, and ID2) .
loading...
    loading...
Cat. No.: HY-115543
CAS No.: 1783856-40-5
Purity:  99.13%
Target:  

Wnt β-catenin

Research Areas:  

Cancer

β-catenin-IN-37 is a selective β-Catenin/T-cell factor protein-protein interaction (β-catenin/Tcf PPI) inhibitor. β-catenin-IN-37 inhibits canonical Wnt signaling and the growth of colorectal cancer cells SW480 and HCT116 with the IC50 values of 20 μM and 31 μM, respectively .
loading...
    loading...
Cat. No.: HY-172393
TCF4/β-catenin-IN-1 (Compound 8b) is an inhibitor of TCF4/β-catenin, and induces apoptosis. TCF4/β-catenin-IN-1 up-regulates p53, caspase-3, caspase-8, caspase-9 levels and Bax protein expression as well as down-regulates Bcl-2 protein expression. TCF4/β-catenin-IN-1 can inhibit CYP3A4, CYP1A2, CYP2C19, and shows promising cytotoxic activity in cancer cells .
loading...
    loading...
Cat. No.: HY-124826
CAS No.: 691005-38-6
Synonyms: NSC 109268
Target:  

β-catenin

Research Areas:  

Cancer

BC21 (NSC 109268) is a β-catenin/Tcf4 inhibitor with an IC50 of 5 μM. BC21 effectively inhibits the binding of β-catenin to Tcf4-derived peptides and suppresses β-catenin/Tcf4-driven reporter gene activity. BC21 can be utilized in cancer research .
loading...
    loading...
Cat. No.: HY-P11007
CAS No.: 2579070-02-1
Research Areas:  

Cancer

β-catenin inhibitory peptoid (compound 13) inhibits the β-catenin:TCF interaction with an IC50 of 5.44 µM. β-catenin inhibitory peptoid inhibits both Wnt (IC50 of 0.105 µM) and androgen receptor (AR)-signaling (IC50 of 1.02 µM) in prostate cancer cell lines. β-catenin inhibitory peptoid markedly diminishes cell proliferation of prostate cancer cell lines .
loading...
    loading...
Cat. No.: HY-P10392
CAS No.: 1418863-17-8
Target:  

β-catenin Wnt

Research Areas:  

Cancer

aStAx-35R, a stapled peptide, antagonizes nuclear form of β-catenin and inhibits Wnt signaling. aStAx-35R inhibits competitively the binding of β-catenin to TCF4. aStAx-35R selectively induces growth inhibition of Wnt-dependent cancer cells .
loading...
    loading...